Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sonia Hernandez-Diaz, D.P.H., M.D.

Co-Author

This page shows the publications co-authored by Sonia Hernandez-Diaz and Krista Huybrechts.
Connection Strength

11.780
  1. Safety of Tenofovir Disoproxil Fumarate for Pregnant Women Facing the Coronavirus Disease 2019 Pandemic. Am J Epidemiol. 2021 11 02; 190(11):2339-2349.
    View in: PubMed
    Score: 0.996
  2. Hydroxychloroquine early in pregnancy and risk of birth defects: absence of evidence is not the same as evidence of absence. Am J Obstet Gynecol. 2021 05; 224(5):549-550.
    View in: PubMed
    Score: 0.941
  3. Hydroxychloroquine early in pregnancy and risk of birth defects. Am J Obstet Gynecol. 2021 03; 224(3):290.e1-290.e22.
    View in: PubMed
    Score: 0.921
  4. Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study. BMJ. 2020 02 19; 368:m237.
    View in: PubMed
    Score: 0.885
  5. Maternal Antidepressant Use and Persistent Pulmonary Hypertension of the Newborn--Reply. JAMA. 2015 Sep 22-29; 314(12):1294.
    View in: PubMed
    Score: 0.649
  6. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA. 2015 Jun 02; 313(21):2142-51.
    View in: PubMed
    Score: 0.638
  7. Validity of claims-based algorithms to identify neurodevelopmental disorders in children. Pharmacoepidemiol Drug Saf. 2021 Dec; 30(12):1635-1642.
    View in: PubMed
    Score: 0.248
  8. Response to Invited Commentary: Intermittent opioid use and ischemic placental disease: study quantifies risks, raises questions. Am J Epidemiol. 2021 Sep 15.
    View in: PubMed
    Score: 0.247
  9. Ischemic Placental Disease, Preterm Delivery, and their Association with Opioid Use During Pregnancy. Am J Epidemiol. 2021 Jun 24.
    View in: PubMed
    Score: 0.243
  10. Association of first trimester prescription opioid use with congenital malformations in the offspring: population based cohort study. BMJ. 2021 02 10; 372:n102.
    View in: PubMed
    Score: 0.237
  11. Ondansetron Use in Pregnancy and Congenital Malformations-Reply. JAMA. 2020 05 26; 323(20):2097-2098.
    View in: PubMed
    Score: 0.225
  12. Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study. BMJ. 2020 May 20; 369:m1494.
    View in: PubMed
    Score: 0.225
  13. Intravenous Ondansetron in Pregnancy and Risk of Congenital Malformations. JAMA. 2020 01 28; 323(4):372-374.
    View in: PubMed
    Score: 0.220
  14. The Impact of Technology on the Diagnosis of Congenital Malformations. Am J Epidemiol. 2019 11 01; 188(11):1892-1901.
    View in: PubMed
    Score: 0.217
  15. Poorly Controlled Asthma During Pregnancy Remains Common in the United States. J Allergy Clin Immunol Pract. 2019 Nov - Dec; 7(8):2672-2680.e10.
    View in: PubMed
    Score: 0.212
  16. Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes. Am J Psychiatry. 2018 06 01; 175(6):564-574.
    View in: PubMed
    Score: 0.195
  17. Use of haloperidol versus atypical antipsychotics and risk of in-hospital death in patients with acute myocardial infarction: cohort study. BMJ. 2018 03 28; 360:k1218.
    View in: PubMed
    Score: 0.194
  18. Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations: A Cohort Study From the International Pregnancy Safety Study Consortium. JAMA Psychiatry. 2018 02 01; 75(2):167-175.
    View in: PubMed
    Score: 0.192
  19. Topiramate use early in pregnancy and the risk of oral clefts: A pregnancy cohort study. Neurology. 2018 01 23; 90(4):e342-e351.
    View in: PubMed
    Score: 0.191
  20. Lithium Use in Pregnancy and the Risk of Cardiac Malformations. N Engl J Med. 2017 08 31; 377(9):893-894.
    View in: PubMed
    Score: 0.186
  21. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study. BMJ. 2017 Aug 02; 358:j3326.
    View in: PubMed
    Score: 0.185
  22. Zidovudine use in pregnancy and congenital malformations. AIDS. 2017 07 31; 31(12):1733-1743.
    View in: PubMed
    Score: 0.185
  23. Antipsychotic Medication Use Among Publicly Insured Pregnant Women in the United States. Psychiatr Serv. 2017 Nov 01; 68(11):1112-1119.
    View in: PubMed
    Score: 0.184
  24. Lithium Use in Pregnancy and the Risk of Cardiac Malformations. N Engl J Med. 2017 06 08; 376(23):2245-2254.
    View in: PubMed
    Score: 0.183
  25. Pregabalin use early in pregnancy and the risk of major congenital malformations. Neurology. 2017 May 23; 88(21):2020-2025.
    View in: PubMed
    Score: 0.182
  26. A Propensity-score-based Fine Stratification Approach for Confounding Adjustment When Exposure Is Infrequent. Epidemiology. 2017 03; 28(2):249-257.
    View in: PubMed
    Score: 0.180
  27. Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations. Obstet Gynecol. 2017 01; 129(1):174-184.
    View in: PubMed
    Score: 0.178
  28. Late Pregnancy ß Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia. Pediatrics. 2016 09; 138(3).
    View in: PubMed
    Score: 0.174
  29. Suppression of Substance Abuse Claims in Medicaid Data and Rates of Diagnoses for Non-Substance Abuse Conditions. JAMA. 2016 Mar 15; 315(11):1164-6.
    View in: PubMed
    Score: 0.168
  30. Methodological considerations in assessing the effectiveness of antidepressant medication continuation during pregnancy using administrative data. Pharmacoepidemiol Drug Saf. 2015 Sep; 24(9):934-42.
    View in: PubMed
    Score: 0.160
  31. Statins and congenital malformations: cohort study. BMJ. 2015 Mar 17; 350:h1035.
    View in: PubMed
    Score: 0.157
  32. Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study. Am J Obstet Gynecol. 2015 Mar; 212(3):337.e1-14.
    View in: PubMed
    Score: 0.152
  33. In Reply: Cho et al. Obstet Gynecol. 2014 Sep; 124(3):638.
    View in: PubMed
    Score: 0.151
  34. Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiology. 2014 May; 120(5):1216-24.
    View in: PubMed
    Score: 0.148
  35. Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol. 2014 May; 123(5):997-1002.
    View in: PubMed
    Score: 0.148
  36. Trajectories of Prescription Opioid Utilization During Pregnancy Among Pre-Pregnancy Chronic Users and Risk of Neonatal Opioid Withdrawal Syndrome. Am J Epidemiol. 2021 Oct 13.
    View in: PubMed
    Score: 0.062
  37. The Patterns of Use of Medications for Inflammatory Bowel Disease During Pregnancy in the US and Sweden Are Changing. Inflamm Bowel Dis. 2021 08 19; 27(9):1427-1434.
    View in: PubMed
    Score: 0.061
  38. Chronic prescription opioid use in pregnancy in the United States. Pharmacoepidemiol Drug Saf. 2021 04; 30(4):504-513.
    View in: PubMed
    Score: 0.059
  39. Prescription opioid use after vaginal delivery and subsequent persistent opioid use and misuse. Am J Obstet Gynecol MFM. 2021 03; 3(2):100304.
    View in: PubMed
    Score: 0.059
  40. Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: A population-based cohort study nested in the US Medicaid Analytic eXtract dataset. PLoS Med. 2020 09; 17(9):e1003322.
    View in: PubMed
    Score: 0.057
  41. Rates of Hospitalization and Infection-Related Hospitalization Among Human Immunodeficiency Virus (HIV)-Exposed Uninfected Children Compared to HIV-Unexposed Uninfected Children in the United States, 2007-2016. Clin Infect Dis. 2020 07 11; 71(2):332-339.
    View in: PubMed
    Score: 0.057
  42. Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006-2016: A study in the five Nordic countries, United States, and Australia. Pharmacoepidemiol Drug Saf. 2020 08; 29(8):913-922.
    View in: PubMed
    Score: 0.056
  43. Antipsychotic drug use in pregnancy: A multinational study from ten countries. Schizophr Res. 2020 06; 220:106-115.
    View in: PubMed
    Score: 0.056
  44. Validation of algorithms to identify adverse perinatal outcomes in the Medicaid Analytic Extract database. Pharmacoepidemiol Drug Saf. 2020 04; 29(4):419-426.
    View in: PubMed
    Score: 0.055
  45. Antidiabetic medication use during pregnancy: an international utilization study. BMJ Open Diabetes Res Care. 2019; 7(1):e000759.
    View in: PubMed
    Score: 0.054
  46. ß-Blocker Use in Pregnancy and the Risk for Congenital Malformations. Ann Intern Med. 2019 06 18; 170(12):909-910.
    View in: PubMed
    Score: 0.053
  47. ß-Blocker Use in Pregnancy and the Risk for Congenital Malformations: An International Cohort Study. Ann Intern Med. 2018 11 20; 169(10):665-673.
    View in: PubMed
    Score: 0.050
  48. Frequency of Opioid Dispensing After Vaginal Delivery. Obstet Gynecol. 2018 08; 132(2):459-465.
    View in: PubMed
    Score: 0.050
  49. Anticonvulsants and the risk of perinatal bleeding complications: A pregnancy cohort study. Neurology. 2018 08 07; 91(6):e533-e542.
    View in: PubMed
    Score: 0.049
  50. Using prescription claims to detect aberrant behaviors with opioids: comparison and validation of 5 algorithms. Pharmacoepidemiol Drug Saf. 2019 01; 28(1):62-69.
    View in: PubMed
    Score: 0.049
  51. Trends in use of hydroxychloroquine during pregnancy in systemic lupus erythematosus patients from 2001 to 2015. Lupus. 2018 May; 27(6):1012-1017.
    View in: PubMed
    Score: 0.048
  52. Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study. BMJ. 2017 Mar 06; 356:j895.
    View in: PubMed
    Score: 0.045
  53. Brief Report: Patterns and Secular Trends in Use of Immunomodulatory Agents During Pregnancy in Women With Rheumatic Conditions. Arthritis Rheumatol. 2016 05; 68(5):1183-9.
    View in: PubMed
    Score: 0.042
  54. Calcium Channel Blocker Exposure in Late Pregnancy and the Risk of Neonatal Seizures. Obstet Gynecol. 2015 Aug; 126(2):271-278.
    View in: PubMed
    Score: 0.040
  55. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. BMJ. 2015 May 14; 350:h2102.
    View in: PubMed
    Score: 0.040
  56. Development of a comorbidity index for use in obstetric patients. Obstet Gynecol. 2013 Nov; 122(5):957-965.
    View in: PubMed
    Score: 0.036
  57. Outpatient calcium-channel blockers and the risk of postpartum haemorrhage: a cohort study. BJOG. 2013 Dec; 120(13):1668-76; dicussion 1676-7.
    View in: PubMed
    Score: 0.035
  58. Methylergonovine maleate and the risk of myocardial ischemia and infarction. Am J Obstet Gynecol. 2013 Nov; 209(5):459.e1-459.e13.
    View in: PubMed
    Score: 0.035
  59. Patterns of outpatient antihypertensive medication use during pregnancy in a Medicaid population. Hypertension. 2012 Oct; 60(4):913-20.
    View in: PubMed
    Score: 0.033
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.